JETOUR RHD Models Debut in South Africa, Boosting Globalization Through Wildlife Conservation

JOHANNESBURG,Sept. 23,2024--On September 20,2024,local time,JETOUR held a launch event in Johannesburg,South Africa,introducing two RHD models: JETOUR DASHING and X70PLUS,which marks JETOUR\'s acceler

09-24

Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships

SINGAPORE,Sept. 23,2024-- Advantech (TWSE: 2395),a global leader in industrial IoT and embedded computing solutions,has officially inaugurated its expanded regional office in Singapore. This strategic

09-24

"Black technology" to help the autumn inspection efficient and orderly

KUITUN,China,Sept. 23,2024-- Recently,the State Grid Kuitun Power Supply Company kicked off the autumn inspection,comprehensively investigated risks and hidden dangers,strictly implemented the safety

09-24

3B Scientific Acquires Veterinary Simulator Industries

HAMBURG,Germany,Sept. 23,2024-- 3B Scientific,a global leader in the manufacturing and marketing of medical and scientific educational products,announced today that it has acquired Veterinary Simulat

09-24

Summit Planners: Will Planning for Different Life Stages

SINGAPORE,Sept. 23,2024-- To raise awareness of the importance of Will Planning,Summit Planners are running monthly Will Planning seminars to encourage the members of the public to take action to ens

09-24

When Technology and Fashion Illuminate Paris Fashion Week: Yaber and Pantone Color Institute Debut Exclusive K3 Projector in Lunar Rock

PARIS,Sept. 23,2024-- Yaber,a pioneer of entertainment projectors,has collaborated with the Pantone Color Institute to unveil a limited edition K3 projector in the exclusive Yaber Lunar Rock shade at

09-24

Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand

XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new dru

09-24

Impressive preliminary objective response rates (ORR) of 36% in NSCLC and 80% in EGFRmut NSCLC: Interim Results of a Phase 1 Study of BC3195, a First-in-Class ADC Targeting CDH3, Presented by BioCity at ESMO 2024

SHANGHAI,Sept. 23,2024-- On September 14,2024,BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadheri

09-24

State Grid Shizuishan Power Supply Company: Escort sturgeon farming to help rural revitalization

SHIZUISHAN,China,Sept. 23,2024-- On the edge of the rippling ponds,sturgeon swim merrily,heralding another bumper harvest. Recently,the staff of the State Grid Shizuishan Power Supply Company walked i

09-24

North Texas Innovation Alliance Members and Curiosity Lab at Peachtree Corners Announce SCEWC Smart Cities Global Startup Challenge

Pitching Challenge to Reward Companies with United States Pilot and Funding Opportunities DALLAS,Sept. 23,2024--North Texas Innovation Alliance (NTXIA),a 501(c)3 regional consortium of over 40 munici

09-24